Drug Delivery Polymer Market - Forecasts from 2018 to 2023
The drug delivery polymer market is projected to grow at a CAGR of XX.XX% to reach US$XX.XXX billion by 2023, from US$XX.XXX billion in 2017. Polymers used for the delivery of drugs into an animal during pre-clinical and humans during clinical trials (for the study of drug dynamics) and also during the medical procedures or after the procedure is over are known as Drug Delivery Polymers. They act as a carrier for the controlled release of drugs into the body. Therefore, they find immense potential in healthcare and pharmaceuticals. On the basis of their characteristics which include natural or synthetic or combination of both, protein-based, polyester etc., degradable or non-biodegradable and hydrophilic or hydrophobic these polymers are inert drug carriers and thus are considered safe for consumption.
Switzerland, from the European region, has the highest production of pharmaceuticals. The multinational corporations, Roche and Novartis have their headquarters in Basel. Furthermore, the growing healthcare expenditure, increasing elderly population worldwide and a worldwide prevalence of chronic diseases are some of the drivers driving the market growth.
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the drug delivery polymer value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the drug delivery polymer market.
Major industry players profiled as part of the report are AdhexPharma, Polymer Therapeutics, LLC, Bezwada Biomedical, LLC., POLYVATION BV and Poly-Med, Inc. among others.
The drug delivery polymer market has been analyzed through following segments:
By Material Type
PLGA (Polylactic-co-glycolic acid)
PGA (Poly-l-glutamic acid)
Polylactic acid (Biodegradable)
Temperature responsive polymer
By Drug Delivery Application
Biodegradable or Chemically controlled
Externally triggered (i.e. pH, temperature etc.)
By End User
Academic and Research Institutes
Middle East and Africa
Key insights offered
What will be the drug delivery polymer market size from 2017 to 2023?
How are the major drivers and restraints affecting the drug delivery polymer market growth and the opportunities which exist for key vendors?
Which segment and region will drive or lead the market growth and why?
A comprehensive analysis of competitive landscape and key market participants’ behaviour
Key strategies being adopted by vendors, with in-depth analysis along with their impact on competition and market growth.
Polymer Therapeutics, LLC
Bezwada Biomedical, LLC.
Evonik Industries AG
The Lubrizol Corporation